In this op-ed piece in The National Post, AIMS Fellow in Health Care Economics Brian Ferguson clearly explains why Canadians should be wary of US plans to allow re-importation of pharmaceuticals from Canada.

According to Ferguson, “The United States has a serious problem with regard to the accessibility of pharmaceuticals. Canada cannot solve this problem. American legislators are fantasizing the access problem will go away if drugs cross the Canadian border a couple of times. And Canadians might ponder this: Once the U.S. realizes that re-importation is a device, not for saving American consumers money, but for putting profits into the pockets of Canadian middlemen, we’ll go from hero to arch villain and be in for another rousing chorus of ‘Blame Canada.’”

To find out more, read the complete article by clicking here.